These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
501 related items for PubMed ID: 16762617
21. Appendectomy is an independent protective factor for ulcerative colitis: results of a multicentre case control study. The Italian Group for the Study of the Colon and Rectum (GISC). Parrello T, Pavia M, Angelillo IF, Monteleone G, Riegler G, Papi G, D'Incà R, Annese V, Tonelli F, Caprilli R, Pallone F. Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):208-11. PubMed ID: 9646210 [Abstract] [Full Text] [Related]
22. Modelling dysplasia detection in ulcerative colitis: clinical implications of surveillance intensity. Awais D, Siegel CA, Higgins PD. Gut; 2009 Nov; 58(11):1498-503. PubMed ID: 19651634 [Abstract] [Full Text] [Related]
23. Results of cancer surveillance in ulcerative colitis. Suzuki K, Muto T, Shinozaki M, Higuchi Y, Sawada T, Saito Y. J Gastroenterol; 1995 Nov; 30 Suppl 8():40-2. PubMed ID: 8563886 [Abstract] [Full Text] [Related]
27. Is colonoscopy alone sufficient to screen for ulcerative colitis-associated colorectal carcinoma? Bruewer M, Krieglstein CF, Utech M, Bode M, Rijcken E, Anthoni C, Laukoetter MG, Schuermann G, Senninger N. World J Surg; 2003 May; 27(5):611-5. PubMed ID: 12715233 [Abstract] [Full Text] [Related]
28. Inflammatory bowel diseases, 5-aminosalicylic acid and sulfasalazine treatment and risk of acute pancreatitis: a population-based case-control study. Munk EM, Pedersen L, Floyd A, Nørgård B, Rasmussen HH, Sørensen HT. Am J Gastroenterol; 2004 May; 99(5):884-8. PubMed ID: 15128355 [Abstract] [Full Text] [Related]
29. The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis. Wolf JM, Rybicki LA, Lashner BA. Aliment Pharmacol Ther; 2005 Nov 01; 22(9):783-8. PubMed ID: 16225486 [Abstract] [Full Text] [Related]
30. Clinicopathological study of colorectal cancer occurring in patients with ulcerative colitis: results from a single hospital in Japan. Fujita T, Ando T, Watanabe O, Hasegawa M, Miyake N, Kondo S, Kato T, Ishiguro K, Nakamura M, Miyahara R, Ohmiya N, Niwa Y, Goto H. Hepatogastroenterology; 2010 Nov 01; 57(99-100):487-92. PubMed ID: 20698214 [Abstract] [Full Text] [Related]
31. Crohn's colitis: the incidence of dysplasia and adenocarcinoma in surgical patients. Maykel JA, Hagerman G, Mellgren AF, Li SY, Alavi K, Baxter NN, Madoff RD. Dis Colon Rectum; 2006 Jul 01; 49(7):950-7. PubMed ID: 16729218 [Abstract] [Full Text] [Related]
32. Predictors of pouchitis after ileal pouch-anal anastomosis: a retrospective review. Hoda KM, Collins JF, Knigge KL, Deveney KE. Dis Colon Rectum; 2008 May 01; 51(5):554-60. PubMed ID: 18266037 [Abstract] [Full Text] [Related]
33. Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population. Hata K, Watanabe T, Kazama S, Suzuki K, Shinozaki M, Yokoyama T, Matsuda K, Muto T, Nagawa H. Br J Cancer; 2003 Oct 06; 89(7):1232-6. PubMed ID: 14520452 [Abstract] [Full Text] [Related]
34. Colorectal neoplasia in veterans is associated with Barrett's esophagus but not with proton-pump inhibitor or aspirin/NSAID use. Siersema PD, Yu S, Sahbaie P, Steyerberg EW, Simpson PW, Kuipers EJ, Triadafilopoulos G. Gastrointest Endosc; 2006 Apr 06; 63(4):581-6. PubMed ID: 16564855 [Abstract] [Full Text] [Related]
35. Review of chronic ulcerative colitis cases at King Hussein Medical Centre, Jordan. Ghazzawi I, Al-Mrayat Z. East Mediterr Health J; 2007 Apr 06; 13(2):294-300. PubMed ID: 17684851 [Abstract] [Full Text] [Related]
36. Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study. Lakatos L, Mester G, Erdelyi Z, David G, Pandur T, Balogh M, Fischer S, Vargha P, Lakatos PL. Inflamm Bowel Dis; 2006 Mar 06; 12(3):205-11. PubMed ID: 16534422 [Abstract] [Full Text] [Related]
37. The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years. Manninen P, Karvonen AL, Huhtala H, Aitola P, Hyöty M, Nieminen I, Hemminki H, Collin P. J Crohns Colitis; 2013 Dec 06; 7(11):e551-7. PubMed ID: 23619008 [Abstract] [Full Text] [Related]
38. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study. Henriksen M, Jahnsen J, Lygren I, Stray N, Sauar J, Vatn MH, Moum B, IBSEN Study Group. Gut; 2008 Nov 06; 57(11):1518-23. PubMed ID: 18566104 [Abstract] [Full Text] [Related]
39. Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal. Cassinotti A, Actis GC, Duca P, Massari A, Colombo E, Gai E, Annese V, D'Albasio G, Manes G, Travis S, Porro GB, Ardizzone S. Am J Gastroenterol; 2009 Nov 06; 104(11):2760-7. PubMed ID: 19623172 [Abstract] [Full Text] [Related]
40. Altered expression of CK7 and CK20 in preneoplastic and neoplastic lesions in ulcerative colitis. Stenling R, Lindberg J, Rutegård J, Palmqvist R. APMIS; 2007 Nov 06; 115(11):1219-26. PubMed ID: 18092953 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]